DBV Technologies (DBVT) Current Leases (2019 - 2026)
DBV Technologies (DBVT) reported Current Leases of $1.0 million for Q1 2026, up 41.04% year-over-year from $709000.0 in Q1 2025, and down 9.09% on a QoQ basis from $1.1 million in Q4 2025.
DBV Technologies (DBVT) has 8 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Current Leases rose 41.04% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 41.04% YoY) and the FY2025 annual result came in at $1.1 million, up 68.2% from the prior year.
- Current Leases declined to $1.0 million in Q1 2026 per DBVT's latest filing, from $1.1 million in the prior quarter.
- Across five years, Current Leases topped out at $2.0 million in Q1 2022 and bottomed at $232000.0 in Q1 2024.
- The 5-year median for Current Leases is $1.1 million (2025), against an average of $1.2 million.
- The widest annual swing landed in 2024, when Current Leases tumbled 87.94%; it then soared 205.6% in 2025.
- Tracing DBVT's Current Leases over 5 years: stood at $1.9 million in 2022, then tumbled by 39.6% to $1.1 million in 2023, then slumped by 42.83% to $654000.0 in 2024, then jumped by 68.2% to $1.1 million in 2025, then retreated by 9.09% to $1.0 million in 2026.
- Per Business Quant, the three latest DBVT Current Leases figures stand at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 709,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | 3.31 Mn |
| Dec 31, 2020 | 3.71 Mn |
| Jun 30, 2020 | 3.69 Mn |
| Dec 31, 2019 | 3.63 Mn |
| Sep 30, 2019 | 3.65 Mn |
| Jun 30, 2019 | 3.55 Mn |